Marie Matsuda

998 total citations
28 papers, 836 citations indexed

About

Marie Matsuda is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Marie Matsuda has authored 28 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 27 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in Marie Matsuda's work include Hepatitis C virus research (26 papers), Hepatitis B Virus Studies (24 papers) and Liver Disease Diagnosis and Treatment (21 papers). Marie Matsuda is often cited by papers focused on Hepatitis C virus research (26 papers), Hepatitis B Virus Studies (24 papers) and Liver Disease Diagnosis and Treatment (21 papers). Marie Matsuda collaborates with scholars based in Japan. Marie Matsuda's co-authors include Hiromitsu Kumada, Yoshiyuki Suzuki, Mariko Kobayashi, Satoshi Saitoh, Masahiro Kobayashi, Norio Akuta, Takashi Someya, Fumitaka Suzuki, Yasuji Arase and Tetsuya Hosaka and has published in prestigious journals such as Journal of Medical Virology, Journal of Gastroenterology and Hepatology and Journal of Gastroenterology.

In The Last Decade

Marie Matsuda

27 papers receiving 788 citations

Peers

Marie Matsuda
Sachiyo Watahiki Japan
J.M. Sánchez‐Tapias Spain
Minoru Horikita Japan
F. Vinelli Italy
AM Di Bisceglie United States
Fernando Sogari Italy
Dessislava I. Dimitrova United States
F Zechini Italy
N.C. Tassopoulos Greece
K Ohba Japan
Sachiyo Watahiki Japan
Marie Matsuda
Citations per year, relative to Marie Matsuda Marie Matsuda (= 1×) peers Sachiyo Watahiki

Countries citing papers authored by Marie Matsuda

Since Specialization
Citations

This map shows the geographic impact of Marie Matsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Matsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Matsuda more than expected).

Fields of papers citing papers by Marie Matsuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Matsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Matsuda. The network helps show where Marie Matsuda may publish in the future.

Co-authorship network of co-authors of Marie Matsuda

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Matsuda. A scholar is included among the top collaborators of Marie Matsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Matsuda. Marie Matsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Fumitaka, Norio Akuta, Yoshiyuki Suzuki, et al.. (2006). Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants. Journal of Medical Virology. 78(3). 341–352. 18 indexed citations
2.
Kobayashi, Mariko, Fumitaka Suzuki, Norio Akuta, et al.. (2005). Virological differences between patients infected with subtypes Ba and Bj of hepatitis B virus genotype B. Journal of Gastroenterology and Hepatology. 20(4). 570–576. 8 indexed citations
3.
Akuta, Norio, Fumitaka Suzuki, Mariko Kobayashi, et al.. (2005). Virological and Biochemical Relapse after Discontinuation of Lamivudine Monotherapy for Chronic Hepatitis B in Japan: Comparison with Breakthrough Hepatitis during Long-Term Treatment. Intervirology. 48(2-3). 174–182. 15 indexed citations
4.
Suzuki, Yoshiyuki, Mariko Kobayashi, Kenji Ikeda, et al.. (2005). Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan. Journal of Medical Virology. 76(1). 33–39. 91 indexed citations
5.
Kobayashi, Mariko, Fumitaka Suzuki, Yasuji Arase, et al.. (2004). Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001. Journal of Gastroenterology. 39(9). 844–850. 41 indexed citations
6.
Suzuki, Fumitaka, Akihito Tsubota, Yasuji Arase, et al.. (2004). Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis. Journal of Gastroenterology. 39(11). 1078–1084. 9 indexed citations
7.
Tsubota, Akihito, Yasuji Arase, Fumitaka Suzuki, et al.. (2004). Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long‐term lamivudine therapy for hepatitis B e antigen‐positive chronic hepatitis B. Journal of Medical Virology. 73(1). 7–12. 11 indexed citations
8.
Matsuda, Marie, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.. (2004). YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine. Journal of Medical Virology. 74(2). 361–366. 28 indexed citations
9.
Sezaki, Hitomi, Masahiro Kobayashi, Tetsuya Hosaka, et al.. (2004). Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection. Journal of Gastroenterology. 39(6). 550–556. 28 indexed citations
10.
Matsuda, Marie, Fumitaka Suzuki, Yoshiyuki Suzuki, et al.. (2004). Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine. Journal of Gastroenterology. 39(1). 34–40. 25 indexed citations
11.
Kobayashi, Mariko, Yasuji Arase, Kenji Ikeda, et al.. (2003). Precore Wild-Type Hepatitis B Virus with G1896 in the Resolution of Persistent Hepatitis B Virus Infection. Intervirology. 46(3). 157–163. 10 indexed citations
12.
Akuta, Norio, Fumitaka Suzuki, Mariko Kobayashi, et al.. (2003). Virological and biochemical relapse according to YMDD motif mutant type during long‐term lamivudine monotherapy. Journal of Medical Virology. 71(4). 504–510. 18 indexed citations
13.
Suzuki, Fumitaka, Akihito Tsubota, Yasuji Arase, et al.. (2003). Efficacy of Lamivudine Therapy and Factors Associated with Emergence of Resistance in Chronic Hepatitis B Virus Infection in Japan. Intervirology. 46(3). 182–189. 72 indexed citations
14.
Suzuki, Fumitaka, Akihito Tsubota, Yasuji Arase, et al.. (2003). HBe antigen loss during lamivudine therapy is not caused by mutations in precore and core promoter genes in patients with chronic hepatitis B. Journal of Medical Virology. 70(3). 355–360. 2 indexed citations
15.
Kobayashi, Mariko, Yasuji Arase, Kenji Ikeda, et al.. (2002). Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan. Journal of Medical Virology. 68(4). 522–528. 49 indexed citations
16.
Kobayashi, Mariko, Yasuji Arase, Kenji Ikeda, et al.. (2002). Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C. Journal of Gastroenterology. 37(1). 35–39. 63 indexed citations
17.
Kobayashi, Mariko, Kazuaki Chayama, Yasuji Arase, et al.. (1999). Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6. Journal of Gastroenterology. 34(4). 505–509. 11 indexed citations
18.
Kobayashi, Mariko, Hiromitsu Kumada, Yasuji Arase, et al.. (1998). Usefulness of hepatitis C virus RNA counts by second generation HCV bDNA-probe in chronic hepatitis C based on the HCV genotype. Journal of Gastroenterology. 33(2). 223–228. 1 indexed citations
19.
Suzuki, Yoshiyuki, Kenji Ikeda, Satoshi Saitoh, et al.. (1997). Long-term observation of four patients with early stage of primary biliary cirrhosis(PBC).. Kanzo. 38(2). 96–100.
20.
Suzuki, Yoshiyuki, Kenji Ikeda, Satoshi Saitoh, et al.. (1996). A prospective randamized admininstration of Stronger-Neo-Minophagen C as an adjuvant therapy for chronic hepatitis type C treated with interferon.. Kanzo. 37(7). 363–367. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sachiyo Watahiki Breakdown of academic impact, for papers by J.M. Sánchez‐Tapias Breakdown of academic impact, for papers by Minoru Horikita Breakdown of academic impact, for papers by F. Vinelli Breakdown of academic impact, for papers by AM Di Bisceglie Breakdown of academic impact, for papers by Fernando Sogari Breakdown of academic impact, for papers by Dessislava I. Dimitrova Breakdown of academic impact, for papers by F Zechini Breakdown of academic impact, for papers by N.C. Tassopoulos Breakdown of academic impact, for papers by K Ohba
Rankless by CCL
2026